King Pharmaceuticals Company Description
King Pharmaceuticals might not rule the drug market, but it doesn't mind taking the reigns over on certain products under development. The company is engaged in marketing pain management drugs and developing later-stage pharmaceutical candidates in the areas of neuroscience and acute care. Already it has a portfolio of branded prescription products, including chronic pain drug Avinza, muscle relaxant Skelaxin, and blood-loss control aid Thrombin-JMI. It also produces emergency drug delivery devices through subsidiary Meridian Medical Technologies and medicated feed additives through Alpharma Animal Health; King acquired rival Alpharma for $1.6 billion in late 2008.
View the Comprehensive Company Description for King Pharmaceuticals
The Company Description provides a historical perspective of King Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of King Pharmaceuticals's evolution in the marketplace.
